Showing results (81-90 of 91) with videos related to

Sort By:
Pageof 10
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 31, 2019
Voxel Forecast for Precision Oncology: Predicting Spatially Variant and Multiscale Cancer Therapy Response on Longitudinal Quantitative Molecular ImagingStephen R Bowen, Daniel S Hippe, W Art Chaovalitwongse, et al.
Discover Oncology|September 1, 2022
Radiation and immune checkpoint inhibitor-mediated pneumonitis risk stratification in patients with locally advanced non-small cell lung cancer: role of functional lung radiomics?Hannah M T Thomas, Daniel S Hippe, Parisa Forouzannezhad, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 5, 2019
Phase I Study of a CD45-Targeted Antibody-Radionuclide Conjugate for High-Risk LymphomaRyan D Cassaday, Oliver W Press, John M Pagel, et al.
The International Journal of Cardiovascular Imaging|August 18, 2015
High resolution FDG-microPET of carotid atherosclerosis: plaque components underlying enhanced FDG uptakeJin Liu, William S Kerwin, James H Caldwell, et al.
Molecular Cancer Therapeutics|July 3, 2025
Pretargeted Anti-CD20 Radioimmunotherapy with scFv Fusion Protein Safely Combines with BEAM and ASCT in patients with High-Risk B-cell LymphomasJohnnie J Orozco, Manuela C Matesan, Sally J Lundberg, et al.
Cell Reports|April 15, 2014
Testing the role of myeloid cell glucose flux in inflammation and atherosclerosisTomohiro Nishizawa, Jenny E Kanter, Farah Kramer, et al.
Physics in Medicine and Biology|October 7, 2020
Sensitivity analysis of FDG PET tumor voxel cluster radiomics and dosimetry for predicting mid-chemoradiation regional response of locally advanced lung cancerChunyan Duan, W Art Chaovalitwongse, Fangyun Bai, et al.
EJNMMI Research|April 27, 2023
Glypican-3 targeted positron emission tomography detects sub-centimeter tumors in a xenograft model of hepatocellular carcinomaKevin P Labadie, Adrienne L Lehnert, Aimee L Kenoyer, et al.
Scientific Reports|February 13, 2021
Glypican-3 targeted delivery of 89Zr and 90Y as a theranostic radionuclide platform for hepatocellular carcinomaKevin P Labadie, Andrew D Ludwig, Adrienne L Lehnert, et al.
Advances in Radiation Oncology|April 7, 2022
Prognostic Value of Early Fluorodeoxyglucose-Positron Emission Tomography Response Imaging and Peripheral Immunologic Biomarkers: Substudy of a Phase II Trial of Risk-Adaptive Chemoradiation for Unresectable Non-Small Cell Lung CancerStephen R Bowen, Daniel S Hippe, Hannah M Thomas, et al.
Pageof 10